Skip to main content

Table 1 Patient Cohort Characteristics of the Present Study

From: Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation

 Range: 39-78 y; average age: 63.7 ± 7.5y
Patient No. in both Sex
 M:32, F: 25;
Patient No. in different tumor Grade
 G1:15; G2:18; G3:24;
Survival time
 Range: 3-63.2 M, median:13 M, average: 20.03 M
Patient No. of Death during follow-up according to different TN-C expression
 <average TN-C expression: 4; >average TN-C expression:18